RSPEvsREVSETF Comparison
VS
Invesco ESG S&P 500 Equal Weight ETF (RSPE) belongs to the US Large Cap segment. Columbia Research Enhanced Value ETF (REVS) is part of the US Large Cap Value segment. RSPE's top 3 sector exposures are Finance, Technology and Healthcare. In contrast, REVS's top sector exposures are Technology, Finance and Healthcare. Both RSPE and REVS have the same Total Expense Ratio (TER) of 0.2%. RSPE is up 17.89% year-to-date (YTD) with +$29M in YTD flows. REVS performs better with 20.95% YTD performance, and +$202M in YTD flows. Run a side-by-side ETF comparison of RSPE and REVS below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
RSPE vs REVS performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 10/23/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | RSPE REVS | +2.43%+3.08% | +3.57%+5.28% | +17.89%+20.95% | +20.71%+24.23% | +74.58%+84.95% | n/a+80.04% |
| Flows | RSPE REVS | +$2M+$35M | +$5M+$50M | +$29M+$202M | +$36M+$256M | +$52M+$303M | -+$313M |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | RSPE REVS | +10.91%+9.67% | +12.38%+11.02% | +14.30%+13.04% | n/a+14.92% |
| Max drawdown | RSPE REVS | -5.05%-4.80% | -8.83%-6.87% | -18.59%-16.16% | n/a-17.78% |
| Max drawdown duration | RSPE REVS | 65d50d | 65d66d | 219d211d | n/a448d |
Trading data
RSPE | REVS | |
Last sale 10/23/2026 at 1:30 PM | $34.71 | $34.20 |
| Previous close 10/22/2026 | $35.00 | $34.41 |
| Consolidated volume 10/22/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of September 30, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
RSPE | REVS | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Main metrics
Last update 10/23/2026 at 1:30 PM
Live
Closed
RSPE | REVS | |
|---|---|---|
| Last price | $34.71 | $34.20 |
| 1D performance | -0.85% | -0.61% |
| AuM | $74.56 M | $393.13 M |
| E/R | 0.2% | 0.2% |
Characteristics
RSPE | REVS | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | Invesco | Columbia Threadneedle Investments |
| Benchmark | S&P 500 Equal Weight Scored & Screened Leaders Select Index | Beta Advantage Research Enhanced U.S. Value Index |
| N° of holdings | 182 | 296 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | November 17, 2021 | September 25, 2019 |
| ESG | Yes | No |
Advertisement
Exposure
Countries
RSPE
USA
95%
Other
5%
REVS
USA
98.4%
Other
1.6%
Sectors
RSPE
Finance
23.09%
Technology
18.24%
Healthcare
14.53%
Industrials
13.49%
Consumer Non-Cycl.
8.46%
Other
22.19%
REVS
Technology
23.11%
Finance
20.93%
Healthcare
11.15%
Consumer Non-Cycl.
10.87%
Industrials
8.44%
Other
25.5%
Diversification
RSPE
Total weight of top 15 holdings out of 15
11.49%
REVS
Total weight of top 15 holdings out of 15
39.73%
Top 15 holdings
Data as of August 31, 2026
RSPE
Moderna, Inc.
1.59%
Charles River Laboratories International, Inc.
0.81%
PayPal Holdings, Inc.
0.77%
Salesforce, Inc.
0.75%
Expedia Group, Inc.
0.74%
Palo Alto Networks, Inc.
0.74%
Newmont Corp.
0.73%
Workday, Inc.
0.72%
Regeneron Pharmaceuticals, Inc.
0.69%
ServiceNow, Inc.
0.67%
Target Corp.
0.66%
Stanley Black & Decker, Inc.
0.66%
Becton, Dickinson & Co.
0.65%
Microsoft Corp.
0.65%
Freeport-McMoRan, Inc.
0.65%
REVS
Apple, Inc.
7.98%
Microsoft Corp.
7.26%
Bank of America Corp.
3.73%
Chevron Corp.
2.71%
Altria Group, Inc.
2.16%
Citigroup, Inc.
1.86%
Meta Platforms, Inc.
1.80%
Bristol Myers Squibb Co.
1.79%
The Charles Schwab Corp.
1.64%
Cisco Systems, Inc.
1.61%
Newmont Corp.
1.48%
General Motors Co.
1.47%
CVS Health Corp.
1.47%
The TJX Cos., Inc.
1.45%
The Progressive Corp.
1.32%
Frequently asked questions about RSPE and REVS
How have the RSPE and REVS ETFs performed in 2026?
As of October 23, 2026, RSPE is up 17.89% year-to-date (YTD), while REVS has returned 20.95%. That puts REVS better performer ahead so far this year.
Which ETF is attracting more investor money: RSPE or REVS?
Year-to-date, the RSPE ETF saw +$29M in flows, compared to +$202M for REVS.
Which ETF is more volatile: RSPE or REVS?
Over the past year, RSPE had a volatility of 12.38%, while REVS experienced 11.02%.
Which ETF is bigger: RSPE or REVS?
As of October 23, 2026, RSPE holds $74.56 M in assets under management (AUM), while REVS manages $393.13 M.
What sectors do the RSPE and REVS ETFs invest in?
RSPE leans toward sectors like Finance, Technology and Healthcare. Meanwhile, REVS focuses on Technology, Finance and Healthcare.
What are the top holdings of the RSPE ETF and REVS ETF?
RSPE top holdings include Moderna, Inc., Charles River Laboratories International, Inc. and PayPal Holdings, Inc.. REVS holds in its top three: Apple, Inc., Microsoft Corp. and Bank of America Corp..
Which ETF is more diversified: RSPE or REVS?
RSPE holds 184 securities with 11.49% of its assets in the top 15. REVS has 298 securities and a top 15 weight of 39.73%.
Advertisement
Latest news about RSPE & REVS
Advertisement
